Drug
Alxn2050 MR Prototype
Alxn2050 MR Prototype: highest development phase Phase 1, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALXN2050 MR Prototype Tablet NCT05780645 | Phase 1 | Healthy Participants |
Latest
No recent events.
Follow Alxn2050 MR Prototype on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.